Blog
- Recent Advances In Hematology 2022: ADCs, Bispecific Antibodies, CAR-T Cells…
- Emerging Multiple Myeloma Therapies: mAbs, ADCs, CAR-T Cells & Bispecific Antibodies
- Claudin18.2 Targeted Therapies In Cancer
- FDA Approves Tivdak - First Tissue Factor (TF)-Targeted Antibody Conjugate Drug (ADC)
- ADC Drugs Global Sales of 2021 and Future Prospects
- Global Sales of ADCs in 2022 – UP to 7 Billion
- GLP-1R Agonists for Weight Loss
- Clinical Development of ADC Drugs Targeting TROP-2
- PEGylated Liposomes in the Clinic and Clinical Trials
- PROTACs VS. Traditional Small Molecule Inhibitors